{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:34:35Z","timestamp":1760132075666},"reference-count":26,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2010,2,28]]},"DOI":"10.2217\/fon.09.162","type":"journal-article","created":{"date-parts":[[2010,2,10]],"date-time":"2010-02-10T17:35:45Z","timestamp":1265823345000},"page":"201-207","source":"Crossref","is-referenced-by-count":6,"title":["Ixabepilone Plus Capecitabine with Capecitabine Alone for Metastatic Breast Cancer"],"prefix":"10.1080","volume":"6","author":[{"given":"Lun","family":"Li","sequence":"first","affiliation":[{"name":"Evidence-Based Medicine Center and Second Clinical Medical College, Lanzhou University, Gansu Lanzhou730000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center and First Clinical Medical College, Lanzhou University, Gansu Lanzhou730000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehu","family":"Yang","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center, Lanzhou University, Gansu Lanzhou730000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Tian","sequence":"additional","affiliation":[{"name":"Evidence-based Medicine Center, Lanzhou University, Ong Gang West Road NO 199 Lanzhou city, Gansu province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Sun","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center and Second Clinical Medical College, Lanzhou University, Gansu Lanzhou730000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqin","family":"Jia","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center and School of Basic Medical Sciences, Lanzhou University, Gansu Lanzhou730000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center and First Clinical Medical College, Lanzhou University, Gansu Lanzhou730000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Yi","sequence":"additional","affiliation":[{"name":"Evidence-Based Medicine Center and First Clinical Medical College, Lanzhou University, Gansu Lanzhou730000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,2,10]]},"reference":[{"key":"e_1_3_2_2_1_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.8.2197"},{"key":"e_1_3_2_2_2_1","first-page":"1","article-title":"Current management of metastatic breast cancer.","volume":"26","author":"Perez EA","year":"1999","unstructured":"Perez EA : Current management of metastatic breast cancer.Semin. Oncol.26, 1\u201310 (1999).","journal-title":"Semin. Oncol."},{"key":"e_1_3_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602179"},{"key":"e_1_3_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(01)00486-7"},{"key":"e_1_3_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.071"},{"key":"e_1_3_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1706"},{"key":"e_1_3_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-6-617"},{"key":"e_1_3_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.485"},{"key":"e_1_3_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.11.007"},{"key":"e_1_3_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1383"},{"key":"e_1_3_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600261"},{"key":"e_1_3_2_2_12_1","first-page":"2325","article-title":"Epothilones, a new class of microtubule-stabilizing agents with a Taxol-like mechanism of action.","volume":"55","author":"Bollag DM","year":"1995","unstructured":"Bollag DM , McQueneyPA, ZhuJet al.: Epothilones, a new class of microtubule-stabilizing agents with a Taxol-like mechanism of action.Cancer Res.55, 2325\u20132333 (1995).","journal-title":"Cancer Res."},{"key":"e_1_3_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.3849"},{"key":"e_1_3_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.6557"},{"key":"e_1_3_2_2_15_1","volume-title":"Program and Abstracts of the American Society of Clinical Oncology. Breast cancer symposium","author":"Hortobagyi GN","year":"2008","unstructured":"Hortobagyi GN , PerezE, VrdoljakEet al.: Analysis of overall survival (OS) among patients (pts) with metastatic breast cancer (MBC) receiving either ixabepilone (I) plus capecitabine (C) or C alone: results from two randomized Phase III trials. Program and Abstracts of the American Society of Clinical Oncology. Breast cancer symposium. Washington, DC, USA, 5\u20137 September (2008) (Abstract 186)."},{"key":"e_1_3_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.9102"},{"key":"e_1_3_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.10.024"},{"key":"e_1_3_2_2_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.7535"},{"key":"e_1_3_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.0784"},{"key":"e_1_3_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/17455057.5.2.115"},{"key":"e_1_3_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.0543"},{"key":"e_1_3_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm172"},{"key":"e_1_3_2_3_2_1","unstructured":"Christus Santa Rosa: Breast health awareness: join the fight against breast cancer (2009) www.wnba.com\/silverstars\/community\/breast_health_awareness.html"},{"key":"e_1_3_2_3_3_1","unstructured":"Breastcancer.org: Breast cancer statistics (2008) www.breastcancer.org\/symptoms\/understand_bc\/statistics.jsp (Accessed 13 May 2009)"},{"key":"e_1_3_2_3_4_1","unstructured":"National Cancer Institute: Surveillance epidemiology and end results (2009)Estimated new cancer cases and deaths for 2009 http:\/\/seer.cancer.gov\/csr\/1975_2006\/results_single\/sect_01_table.01.pdf"},{"key":"e_1_3_2_3_5_1","unstructured":"Roch\u00e9 H YelleL PeckR: Efficacy results of a Phase II study of ixabepilone in patients with metastatic breast cancer previously treated with an anthracycline. Presented at: The International Union Against Cancer World Cancer Congress . Washington DC USA 8\u201312 July 2006http:\/\/2006.confex.com\/uicc\/uicc\/techprogram\/P8062.HTM(Accessed 4 June 2009)"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.09.162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:12Z","timestamp":1719124932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.09.162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,10]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2,28]]}},"alternative-id":["10.2217\/fon.09.162"],"URL":"https:\/\/doi.org\/10.2217\/fon.09.162","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,10]]}}}